-
Real-world Outcomes in Multiple MyelomaStudy shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.
by Sandra Gordon
-
Some Breast Cancer Patients May Safely Skip RadiationThree presentations at SABCS in December find that it may be safe in certain cases for people with breast cancer to go without radiation.
by Cancer Research Catalyst
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
Forward Look
CDK4/6 Inhibitors in Early-stage Breast CancerA mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
-
Forward Look
A Less Radical ApproachSome women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
by Thomas Celona
-
Forward Look
Ultrasound Device Opens Blood-brain BarrierAn implantable device, along with an infusion of microbubbles, helps increase chemotherapy concentrations for brain cancer.
by Eric Fitzsimmons
-
Forward Look
The Lasting Benefit of Immune Checkpoint InhibitorsStudy suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
by Lindsay Modglin
-
Moving the Needle on Metastatic Breast CancerMetastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
by Erin O’Donnell
-
Survivor Profile
A Can-Do SpiritNavy veteran and two-time cancer survivor Bruce Wright helps other veterans secure benefits for their health conditions.
by Lindsey Konkel Neabore
-
Progress in Rare CancersWith the rise of patient-driven research and registries, scientists are making advances in understanding, diagnosing and treating many of the least common cancer types.
by Kendall K. Morgan
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
